The U.S. FDA said it’s alerting patients, caregivers and health care professionals to immediately inspect certain lots of Amneal and Impax epinephrine auto-injector 0.3 mg to ensure the yellow “stop collar” in the device is present.
- If the auto-injector is missing the stop collar component, the device has the potential of delivering a double dose of epinephrine
- Those who have received Amneal or Impax’s epinephrine auto-injector after Dec. 20, 2018, should immediately visually inspect the auto-injector and contact Amneal or their pharmacies for a free replacement for any defective devices
- Epinephrine auto-injectors are not being recalled; patients and caregivers are ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.